Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia
A prospective cohort study
Bibliographic Data
| ID | 14907666 |
|---|---|
| Authors | Julie Bouscaillou (0000-0001-6656-7753, corresponding author), Tamar Kikvidze, Maia Butsashvili (0000-0002-6554-1567, NeoGenomics (United States)), Konstantine Labartkava, Ina Inaridze, Aurélie Étienne (0000-0002-6155-3843), Diane Le Pluart, George Kamkamidze (0000-0003-0424-0688, NeoGenomics (United States)), Ana Gamezardashvili (NeoGenomics (United States)), David Kharshiladze, Elisabeth Avril, N Luhmann (0000-0003-1108-058X) |
| Year | 2018 |
| Volume | 62 |
| Pages | 104-111 |
| Publication date | 2018-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2018.07.016 |
| PMID | 30384026 |
| OpenAlex | W2898820204 |
| Language | EN |
| Citations received | 1 |
| References cited | 28 |
Antiviral treatment · Chronic hepatitis · Cohort · Cohort study · Environmental health · Hepatitis C virus · Human immunodeficiency virus (HIV · Injection drug use · Prospective cohort study · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Internal Medicine · Virology
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs
Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Human rights and access to hepatitis C treatment for people who inject drugs
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Understanding real-world adherence in the directly acting antiviral era
Hepatitis C among people who inject drugs in Tbilisi, Georgia
Access to hepatitis C treatment for people who inject drugs in low and middle income settings
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,2 |
| Citation span | 2021 - 2021 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |